Physician profile
Delara Pollman
NPI 1962766303
$5,097.49
in general payments reported to CMS, 2019-2025
36 companies · $26.93 in 2025
The $26.93 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,605 · 2022: $2,422 · 2023: $1,044 · 2025: $26.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $561.73 | 2022-2023 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $545.32 | 2021-2023 | Farxiga, Breztri |
| Lilly USA, LLC | $544.24 | 2021-2023 | Mounjaro, Jardiance, Emgality |
| Abbvie INC. | $501.04 | 2021-2023 | |
| Glaxosmithkline, LLC. | $406.07 | 2021-2023 | Shingrix, Trelegy Ellipta |
| Pfizer INC. | $266.64 | 2021-2023 | |
| Amarin Pharma, INC. | $261.74 | 2021-2022 | |
| Amgen INC. | $253.84 | 2021-2023 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $183.92 | 2022 | |
| Upsher-Smith Laboratories LLC | $160.81 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.25 | 2021-2023 | Jardiance, Synjardy, Glyxambi |
| Bayer Healthcare Pharmaceuticals INC. | $150.98 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.01 | 2021-2023 | Xifaxan |
| Dexcom, INC. | $114.45 | 2022-2023 | Dexcom G6 Transmitter |
| Lundbeck LLC | $99.82 | 2022-2023 | Rexulti |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $98.44 | 2022-2023 | Myrbetriq |
| Merck Sharp & Dohme LLC | $84.43 | 2021-2022 | |
| Abbott Laboratories | $70.69 | 2021-2022 | |
| Si-Bone, INC. | $65.43 | 2021-2023 | |
| Exact Sciences Corporation | $49.74 | 2023-2025 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $49.69 | 2021 | |
| Eisai INC. | $46.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $45.75 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.03 | 2023 | Trintellix |
| Jazz Pharmaceuticals INC. | $30.98 | 2021 | |
| Azurity Pharmaceuticals, INC. | $23.19 | 2023 | Horizant |
| Tris Pharma INC | $22.54 | 2022 | |
| Antares Pharma, INC. | $20.62 | 2021 | |
| Sanofi Pasteur INC. | $18.23 | 2022 | |
| Scilex Pharmaceuticals INC. | $15.93 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.92 | 2023 | |
| Becton, Dickinson and Company | $15.20 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.68 | 2022 | |
| Scynexis, INC. | $14.22 | 2022 | |
| Althera Pharmaceuticals LLC | $14.11 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delara Pollman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.